Medeor Therapeutics, Inc.
1 Tower Place
South San Francisco
Tel: (650) 627-44531
About Medeor Therapeutics, Inc.
5 articles with Medeor Therapeutics, Inc.
Medeor Therapeutics, Inc. announced the appointment of Dr. Karen Smith MD., PhD., as its President and Chief Executive Officer.
TrakCel to develop and supply Medeor Therapeutics with cellular supply chain management and orchestration system
TrakCel, the cell and gene therapy supply chain tracking and orchestration system software developer, today announces it has been engaged to build a custom-configured system for Medeor Therapeutics.
Appointed Iqbal Husain, Ph.D., as its Senior Vice President, Program Management, and Michael Zdanowski as its Vice President, Biopharmaceutical Operations.
The award is to support a Phase 3 clinical trial to evaluate the safety and efficacy of MDR-101.
Medeor Receives FDA Clearance Of IND Application And Special Protocol Assessment For Pivotal Clinical Study Of MDR-101